Type Private Founded 2015 | Headquarters United Kingdom | |
 | ||
Traded as LSE: LIVN
NASDAQ: LIVN
S&P 400 Component Key people André-Michel Ballester,
Chief Executive Officer Products Medical devices for cardiac surgery, neuromodulation and cardiac rhythm management Stock price LIVN (LON) US$ 47.30 -1.39 (-2.84%)22 Mar, 3:26 PM GMT - Disclaimer CEO Damien McDonald (1 Jan 2017–) Subsidiaries Cyberonics, Inc., Sorin CRM SAS | ||
Livanova learn how i turned 15 253 into 1 613 442 trading biotech stocks
LivaNova, PLC is a London, England-based medical device manufacturer. The company develops devices used for cardiac surgery, neuromodulation and cardiac rhythm management. The company was formed by a 2015 $2.7B merger between Houston, TX-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on both the London Stock Exchange and NASDAQ.
Contents
History
Cyberonics, Inc. was founded in Houston in 1987. Sorin, also known as Sorin Group, was founded in 1956 by Fiat and Montedison, Italy's two largest industrial groups at that time. The name is an acronym for Società Ricerche Impianti Nucleari (Company for Nuclear Plant Research). In March 2015, the companies announced they would be merging in a $2.7B transaction. The transaction closed and the company began trading under the new stock symbol on Oct. 19. 2015.
Business units
The new combined company announced in May 2015 that it was focused on three product categories and will operate as three business units. The three units are cardiac surgery, with its operating HQ in Italy, cardiac rhythm management, with its operating HQ in France, and neuromodulation, with its operating HQ in Houston.